Back to Journals » Drug Design, Development and Therapy » Volume 13
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,600 | Dovepress* | 5,906+ | 892 | 6,798 | |
PubMed Central* | 694 | 168 | 862 | ||
Totals | 6,600 | 1,060 | 7,660 | ||
*Since 19 December 2019 |
View citations on PubMed Central and Google Scholar